clinical trial · NCT07377721
A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain
Shandong Suncadia Medicine Co., Ltd.·phase1·recruiting·n = 168
Diabetic Peripheral Neuropathic PainHRS-2129 TabletsHRS-2129 PlaceboPregabalin CapsulesPregabalin Capsules Placebo
brief summary
This study aims to investigate the efficacy and safety of HRS-2129 in Chinese diabetic peripheral neuropathic pain (DPNP) in comparison to placebo.
started
Mar 24, 2026
primary completion
Sep 1, 2026
completion
Nov 1, 2026
last updated
Apr 15, 2026
official title
A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Pregabalin Capsule Controlled, Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Chinese Patients With Diabetic Peripheral Neuropathic Pain
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol